Ria for potentially inappropriate medication use in older adults: benefits of a US consensus panel of experts. Arch Intern Med 2003, 163(22):2716?724. four. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly men and women: a national consensus panel. CMAJ 1997, 156(three):385?91. 5. Naugler CT, Brymer C, Stolee P, LIMK2 Inhibitor manufacturer Arcese ZA: Improvement and validation of an enhancing prescribing inside the elderly tool. Can J Clin Pharmacol 2000, 7(two):103?07. 6. van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, Sturkenboom MC: Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria population-based cohort study. Br J Clin Pharmacol 2005, 60(two):137?44. 7. Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997, 157(14):1531?536. eight. Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D: STOPP (Aurora C Inhibitor manufacturer Screening Tool of Older Person’s Prescriptions) and Commence (Screening Tool to Alert doctors to Right Remedy). Consensus validation. Int J Clin Pharmacol Ther 2008, 46(2):72?3. 9. Gallagher P, Baeyens JP, Topinkova E, Madlova P, Cherubini A, Gasperini B, Cruz-Jentoft A, Montero B, Lang PO, Michel JP, O’Mahony D: Inter-rater reliability of STOPP (Screening Tool of Older Persons’ Prescriptions) and Get started (Screening Tool to Alert doctors to Proper Treatment) criteriaBradley et al. BMC Geriatrics 2014, 14:72 biomedcentral/1471-2318/14/Page 9 of10.11.12.13.14.15.16.17.18.19.20.21.22.23.24.25.26.27.28. 29. 30.amongst physicians in six European countries. Age Ageing 2009, 38(five):603?06. Klarin I, Wimo A, Fastbom J: The association of inappropriate drug use with hospitalisation and mortality: a population-based study on the very old. Drugs Aging 2005, 22(1):69?2. Hanlon JT, Maher RL, Lindblad CI, Ruby CM, Twersky J, Cohen HJ, Schmader KE: Comparison of procedures for detecting prospective adverse drug events in frail elderly inpatients and outpatients. Am J Wellness Syst Pharm 2001, 58(17):1622?626. Lund BC, Carnahan RM, Egge JA, Chrischilles EA, Kaboli PJ: Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010, 44(six):957?63. Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D: Potentially inappropriate drugs defined by STOPP criteria along with the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011, 171(11):1013?019. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, Schroll M, Onder G, Sorbye LW, Wagner C, Reissigova J, Bernabei R: Potentially inappropriate medication use amongst elderly dwelling care patients in Europe. JAMA 2005, 293(11):1348?358. Carey IM, De Wilde S, Harris T, Victor C, Richards N, Hilton SR, Cook DG: What elements predict potentially inappropriate principal care prescribing in older people? Evaluation of UK principal care patient record database. Drugs Aging 2008, 25(eight):693?06. Bradley MC, Fahey T, Cahir C, Bennett K, O’Reilly D, Parsons C, Hughes CM: Potentially inappropriate prescribing and expense outcomes for older persons: a cross-sectional study using the Northern Ireland Enhanced Prescribing Database. Eur J Clin Pharmacol 2012, 68(ten):1425?433. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K: Potentially inappropriate prescribing and price outcomes for older persons: a national population study. Br J Clin Pharmacol 2010, 69(five):543?52. Garc Rodr uez LAPGS: Use with the UK Common Practice Analysis Data.
